|
(V1603) |
Aerobic exercise training prevents diaphragm muscle weakness in an animal model of chronic heart failure |
| |
|
N. Mangner, T. S. Bowen, S. Werner, T. Fischer, G. C. Schuler, A. Linke, V. Adams (Leipzig) |
|
|
Diskussion |
|
(V1604) |
15-deoxy-Δ12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined nitric oxide deficit |
| |
|
I. Kadiyska, S. Gehrmann, A. H. Wagner, M. Hecker (Heidelberg) |
|
|
Diskussion |
|
(V1605) |
Silencing MicroRNA-21 ameliorates Diabetic Nephropathy and Vascular Dysfunction |
| |
|
M. Kölling, T. Kaucsár, N. Bukosza, G. Szénási, G. Szénási, M. Godó, J.-K. Park, P. Hamar, H. Haller, T. Thum, J. Lorenzen (Hannover; Budapest, HU) |
|
|
Diskussion |
|
(V1606) |
Local Hemodynamic Forces and Aqueous Cigarette Smoke Extract Affect Development of Endothelial Dysfunction |
| |
|
S. Giebe, C. Brunßen, M. Brux, N. Cockcroft, K. Hewitt, H. Morawietz (Dresden; Southampton, UK) |
|
|
Diskussion |
|
(V1607) |
The contribution of epigallocatechin gallate (EGCG) to endothelial function in humans |
| |
|
M. Lorenz, F. Rauhut, C. Hofer, S. Gwosc, E. Müller, D. Praeger, B. F. Zimmermann, G. Baumann, K. Stangl, V. Stangl (Berlin, Bonn) |
|
|
Diskussion |
|
(V1608) |
Differential effects of exosomes versus microparticles from patients with coronary artery disease as compared to healthy subjects on endothelial cell functions: Critical Role of miR-222 |
| |
|
N. Kränkel, S. Briand, E. Strässler, T. F. Lüscher, U. Landmesser (Berlin; Zürich, CH) |
|
|
Diskussion |